Canada markets closed

Mesoblast Limited (MEOBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.60510.0000 (0.00%)
At close: 10:20AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
2020-06-30
Total Revenue
-
7,501
10,211
7,434
31,614
Operating Expenses
Research Development
-
27,189
32,815
53,012
56,188
Selling General and Administrative
-
53,107
57,967
63,586
50,918
Total Operating Expenses
-
76,790
90,785
115,037
107,028
Operating Income or Loss
-
-69,289
-80,574
-107,603
-75,414
Interest Expense
-
19,444
16,906
10,714
14,716
Total Other Income/Expenses Net
-
5,801
5,891
18,687
2,233
Income Before Tax
-
-82,101
-91,586
-99,630
-87,355
Income Tax Expense
-
-212
-239
-819
-9,415
Income from Continuing Operations
-
-81,889
-91,347
-98,811
-77,940
Net Income
-
-81,889
-91,347
-98,811
-77,940
Net Income available to common shareholders
-
-81,889
-91,347
-98,811
-77,940
Basic EPS
-
-0.11
-0.13
-0.15
-0.14
Diluted EPS
-
-0.11
-0.13
-0.15
-0.14
Basic Average Shares
858,159
779,456
684,386
638,180
557,682
Diluted Average Shares
858,159
779,456
684,386
638,180
557,682